1 INTRODUCTION

    1.1 Study Objectives
    1.2 Market Definition
    1.3 Study Scope

        1.3.1 Market Segmentation & Geographic Spread
        1.3.2 Inclusions & Exclusions

    1.4 Years Considered
    1.5 Currency Considered
    1.6 Stakeholders
    1.7 Summary of Changes

2 MARKET OVERVIEW

    2.1 Introduction
    2.2 Market Dynamics

        2.2.1 Drivers

            2.2.1.1 Rising prevalence of cancer
            2.2.1.2 Increasing preference for minimally  invasive surgeries
            2.2.1.3 Initiatives undertaken by governments  and global health
                    organizations
            2.2.1.4 Increased number of hospitals and  diagnostic centers
            2.2.1.5 Improved reimbursement policies

        2.2.2 Restraints

            2.2.2.1 Increasing product recalls
            2.2.2.2 High risk of infections

        2.2.3 Opportunities

            2.2.3.1 Technological advancements
            2.2.3.2 Growing investments in emerging  economies

        2.2.4 Challenges

            2.2.4.1 Underdeveloped healthcare infrastructure  in emerging
                    economies

    2.3 Industry Trends

        2.3.1 Minimally Invasive Procedures
        2.3.2 Robotic-Assisted Biopsy Devices
        2.3.3 Liquid Biopsy Technology

    2.4 Technology Analysis

        2.4.1 Key Technologies

            2.4.1.1 Robotic-assisted biopsy devices
            2.4.1.2 Optical biopsy technologies
            2.4.1.3 Minimally invasive biopsy devices

        2.4.2 Complementary Technologies

            2.4.2.1 Imaging technologies
            2.4.2.2 Tissue analysis technologies
            2.4.2.3 Artificial intelligence

        2.4.3 Adjacent Technologies

            2.4.3.1 Digital pathology and AI integration
            2.4.3.2 Precision medicine tools
            2.4.3.3 Advanced needle and probe technologies

    2.5 Porter’s Five Forces Analysis

        2.5.1 Threat from New Entrants
        2.5.2 Bargaining Power of Suppliers
        2.5.3 Bargaining Power of Buyers
        2.5.4 Threat from Substitutes
        2.5.5 Intensity of Competitive Rivalry

    2.6 Patent Analysis

        2.6.1 Patent Publication Trends in Biopsy Devices Market
        2.6.2 Insights: Jurisdiction and Top Applicant Analysis

    2.7 Trade Analysis
    2.8 Key Conferences & Events
    2.9 Biopsy Devices Market: Unmet Needs/Expectations of End  Users
    2.10 Ecosystem Analysis
    2.11 Supply Chain Analysis
    2.12 Adjacent Market Analysis

        2.12.1 Breast Biopsy Devices Market

    2.13 Trends/Disruptions Impacting Customer Business
    2.14 Investment & Funding Scenario
    2.15 Impact of AI on Biopsy Devices Market

3 COMPETITIVE LANDSCAPE

    3.1 Overview
    3.2 Key Player Strategies/Right to Win

        3.2.1 Overview of Strategies Adopted By Key Players in  Biopsy Devices
              Market

    3.3 Revenue Analysis
    3.4 Market Share Analysis
    3.5 Company Evaluation Matrix: Key Players, 2023

        3.5.1 Stars
        3.5.2 Emerging Leaders
        3.5.3 Pervasive Players
        3.5.4 Participants
        3.5.5 Company Footprint: Key Players, 2023

            3.5.5.1 Company footprint
            3.5.5.2 Region footprint
            3.5.5.3 Product footprint
            3.5.5.4 Technology footprint
            3.5.5.5 Application footprint
            3.5.5.6 End User footprint

    3.6 Company Valuation & Financial Metrics

        3.6.1 Company Valuation
        3.6.2 Financial Metrics

    3.7 Brand/Product Comparison
    3.8 Competitive Scenario

        3.8.1 Product Launches & Approvals
        3.8.2 Deals
        3.8.3 Expansions

4 COMPANY PROFILES

    4.1 BD (BECTON, DICKINSON AND COMPANY)

        4.1.1 Business overview
        4.1.2 Products/Solutions/Services offered
        4.1.3 Recent developments

    4.2 DEVICOR MEDICAL PRODUCTS, INC

        4.2.1 Business overview
        4.2.2 Products/Solutions/Services offered
        4.2.3 Recent developments

    4.3 MEDTRONIC

        4.3.1 Business overview
        4.3.2 Products/Solutions/Services offered
        4.3.3 Recent developments

    4.4 CARDINAL HEALTH

        4.4.1 Business overview
        4.4.2 Products/Solutions/Services offered
        4.4.3 Recent developments

    4.5 HOLOGIC, INC.

        4.5.1 Business overview
        4.5.2 Products/Solutions/Services offered
        4.5.3 Recent developments

    4.6 B. BRAUN SE

        4.6.1 Business overview
        4.6.2 Products/Solutions/Services offered
        4.6.3 Recent developments

    4.7 OLYMPUS CORPORATION

        4.7.1 Business overview
        4.7.2 Products/Solutions/Services offered
        4.7.3 Recent developments

    4.8 BOSTON SCIENTIFIC CORPORATION

        4.8.1 Business overview
        4.8.2 Products/Solutions/Services offered
        4.8.3 Recent developments

    4.9 FUJIFILM CORPORATION

        4.9.1 Business overview
        4.9.2 Products/Solutions/Services offered
        4.9.3 Recent developments

    4.10 STRYKER

        4.10.1 Business overview
        4.10.2 Products/Solutions/Services offered
        4.10.3 Recent developments

    4.11 TELEFLEX INCORPORATED

        4.11.1 Business overview
        4.11.2 Products/Solutions/Services offered
        4.11.3 Recent developments

    4.12 CONMED CORPORATION

        4.12.1 Business overview
        4.12.2 Products/Solutions/Services offered
        4.12.3 Recent developments

    4.13 MERIT MEDICAL SYSTEMS

        4.13.1 Business overview
        4.13.2 Products/Solutions/Services offered
        4.13.3 Recent developments

    4.14 JOHNSON & JOHNSON SERVICES, INC.

        4.14.1 Business overview
        4.14.2 Products/Solutions/Services offered
        4.14.3 Recent developments

    4.15 COOK GROUP

        4.15.1 Business overview
        4.15.2 Products/Solutions/Services offered
        4.15.3 Recent developments